« Previous
Next »
Early Human Development
Volume 86, Issue 3
, Pages 187-191
, March 2010
Prolonged maternal magnesium administration and bone metabolism in neonates
References
- . The management of preterm labor. Obstet Gynecol. 2002;100(5):1020–1037
- . Effects of magnesium sulfate treatment on perinatal calcium metabolism. II. Neonatal responses. Obstet Gynecol. 1980;56(5):595–600
- . Preterm parturition. Tocolysis using magnesium sulfate. Semin Perinatol. 1981;5:266–273
- . The effects of maternal magnesium sulfate treatment on newborns: a prospective controlled study. J Perinatol. 1998;18(6 Pt 1):449–454
- . Pharmacokinetics of ionized versus total magnesium in subjects with preterm labor and preeclampsia. Am J Obstet Gynecol. 2002;186:1017–1021
- . Long-term tocolysis with combined intravenous terbutaline and magnesium sulfate: a 10-year study of 1000 patients. Obstet Gynecol. 1994;84:369–373
- . Long-term tocolysis with intravenous magnesium sulfate. Obstet Gynecol. 1989;73:373–378
- . Magnesium Supplementation and perinatal hypoxia: outcome of a parallel group randomized trial in pregnancy. BJOG. 2007;114(8):994–1002
- . Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants?. Pediatrics. 1995;95:263–269
- . Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290:2669–2676
- Magnesium sulphate given before very-preterm birth to protect infant brain: the randomized controlled PREMAG trial. BJOG. 2007;114:310–318
- . Benefit of magnesium sulfate given before very preterm birth to protect infant brain. Pediatrics. 2008;121:225–226
- Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn with two-year neurologic outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil. 2008;362:278–288
- . Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in preterm infants. Obstet Gynecol. 2009;114:354–364
- A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008;359:895–905
- . Congenital rickets associated with magnesium sulfate infusion for tocolysis. J Pediatr. 1988;113:1078–1082
- . Hypermagnesemia: a cause of abnormal metaphyses in the neonate. Am J Roentgenol. 1989;152:1071–1072
- . Magnesium tocolysis and neonatal bone abnormalities: a controlled study. Obstet Gynecol. 1991;78:611–614
- . Magnesium sulfate treatment of preterm labor as a cause of abnormal neonatal bone mineralization. J Pediatr Orthop. 1994;14(2):249–253
- . Effects of long-term maternal intravenous magnesium sulfate therapy on neonatal calcium metabolism and bone mineral content. Gynecol Obstet Invest. 1997;43:236–241
- Effect of magnesium sulfate treatment on neonatal bone abnormalities. Gynecol Obstet Invest. 1997;44:82–88
- . Long-term magnesium sulfate tocolysis and maternal osteoporosis in triplet pregnancy: a case report. Am J Perinatol. 1998;15:43–46
- . Bone mineralization in newborns whose mothers received magnesium sulphate for tocolysis of premature labour. Pediatr Radiol. 2004;34:384–386
- . Neonatal bone abnormalities attributable to maternal administration of magnesium sulfate. Pediatr Radiol [Letter]. 2004;34:673–674
- . Adverse maternal and neonatal outcome of prolonged magnesium sulfate tocolysis. Acta Obstet Gynecol. 2006;85:1099–1103
- . Skeletal demineralization and fractures caused by fetal magnesium toxicity. J Perinatol. 2006;26:371–374
PII: S0378-3782(10)00051-4
doi: 10.1016/j.earlhumdev.2010.02.007
© 2010 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Early Human Development
Volume 86, Issue 3
, Pages 187-191
, March 2010
